Your browser doesn't support javascript.
loading
Stimuli-activatable PROTACs for precise protein degradation and cancer therapy.
Gao, Jing; Yang, Lei; Lei, Shumin; Zhou, Feng; Nie, Huijun; Peng, Bo; Xu, Tianfeng; Chen, Xiaohua; Yang, Xiaobao; Sheng, Chunquan; Rao, Yu; Pu, Kanyi; Jin, Jian; Xu, Zhiai; Yu, Haijun.
Afiliação
  • Gao J; Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Yang L; Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Lei S; Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Zhou F; Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Nie H; Center of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Peng B; Information Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Xu T; Center of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
  • Chen X; Center of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
  • Yang X; Gluetacs Therapeutics (Shanghai) Co., Ltd. Shanghai 201306, China.
  • Sheng C; School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
  • Rao Y; School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
  • Pu K; School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 639798, Singapore.
  • Jin J; Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York NY 10029, USA.
  • Xu Z; School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China. Electronic address: xuza@ecnu.edu.cn.
  • Yu H; Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: hjyu@simm.ac.cn.
Sci Bull (Beijing) ; 68(10): 1069-1085, 2023 05 30.
Article em En | MEDLINE | ID: mdl-37169612
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias Limite: Humans Idioma: En Revista: Sci Bull (Beijing) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias Limite: Humans Idioma: En Revista: Sci Bull (Beijing) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Holanda